The DOI matches its Crossref record; 35 of the 35 references it cites were found in a registry or an index.
Increased Tryptophan Metabolism Is Associated With Activity of Inflammatory Bowel Diseases
Open accessAbstract
BACKGROUND & AIMS: Administration of tryptophan and some of its metabolites reduces the severity of colitis in mice, whereas removing tryptophan from the diet increases susceptibility to colitis. Transfer of the intestinal microbiome transfers the colitogenic phenotype from tryptophan starved animals to normally nourished mice. We aimed to systematically evaluate serum levels of tryptophan and its metabolites in patients with inflammatory bowel diseases (IBD), and study their association with clinical and serologic features. METHODS: We studied 535 consecutive patients with IBD (211 with ulcerative colitis [UC], 234 with Crohn's disease [CD]; 236 male), enrolled in Germany from August 2013 through April 2014 and followed until July 2016. Serum samples were collected from patients and 291 matched individuals without IBD (controls); levels of tryptophan were measured using high-performance liquid chromatography. Metabolites of tryptophan were measured in serum from 148 patients and 100 controls by mass spectrometry. We measured levels of interleukin 22 in serum from 28 patients by enzyme-linked immunosorbent assay. Paired stool and serum samples were collected from a subset of patients with active UC (n = 10) or CD (n = 8) to investigate associations between serum levels of tryptophan and composition of the fecal microbiota, analyzed by 16S ribosomal DNA amplicon sequencing. We used real-time polymerase chain reaction to measure levels of messenger RNAs in colonic biopsies from 60 patients with UC, 50 with CD, and 30 controls. We collected information on patients' disease activity scores, medications, laboratory assessments, and clinical examinations during recruitment and follow-up visits. RESULTS: ). We found a negative correlation between serum levels of tryptophan and disease activity or levels of C-reactive protein. Levels of messenger RNAs encoding tryptophan 2,3-dioxygenase-2 and solute carrier family 6 member 19 (also called B0AT1) were significantly decreased in colonic biopsies from patients with IBD compared with controls, whereas level of messenger RNA encoding indoleamine 2,3-dioxygenase-1 was significantly increased. The composition of the fecal microbiota associated with serum levels of tryptophan. Analysis of tryptophan metabolites revealed activation of the kynurenine pathway, based on high levels of quinolinic acid, in patients with IBD compared with controls. Serum concentration of interleukin 22 associated with disease activity in patients with IBD; there was an inverse association between levels of interleukin 22 and serum levels of tryptophan. CONCLUSIONS: In an analysis of serum samples from more than 500 patients with IBD, we observed a negative correlation between serum levels of tryptophan and disease activity. Increased levels of tryptophan metabolites-especially of quinolinic acid-indicated a high activity of tryptophan degradation in patients with active IBD. Tryptophan deficiency could contribute to development of IBD or aggravate disease activity. Interventional clinical studies are needed to determine whether modification of intestinal tryptophan pathways affects the severity of IBD.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Schloss, P. D., Westcott, S. L., Ryabin, T., Hall, J. R., Hartmann, M., Hollister, E. B., Lesniewski, R. A., Oakley, B. B., Parks, D. H., Robinson, C. J., et al. (2009) · Applied and Environmental Microbiology · doi:10.1128/aem.01541-09 · Cited by 19,549
UCHIME improves sensitivity and speed of chimera detection
Edgar, R. C., Haas, B. J., Clemente, J. C., Quince, C., & Knight, R. (2011) · Bioinformatics · doi:10.1093/bioinformatics/btr381 · Cited by 15,114
pROC: an open-source package for R and S+ to analyze and compare ROC curves
Robin, X., Turck, N., Hainard, A., Tiberti, N., Lisacek, F., Sanchez, J.-C., & Müller, M. (2011) · BMC Bioinformatics · doi:10.1186/1471-2105-12-77 · Cited by 13,697
Zelante, T., Iannitti, R. G., Cunha, C., De Luca, A., Giovannini, G., Pieraccini, G., Zecchi, R., D’Angelo, C., Massi-Benedetti, C., Fallarino, F., et al. (2013) · Immunity · doi:10.1016/j.immuni.2013.08.003 · Cited by 2,614
Fadrosh, D. W., Ma, B., Gajer, P., Sengamalay, N., Ott, S., Brotman, R. M., & Ravel, J. (2014) · Microbiome · doi:10.1186/2049-2618-2-6 · Cited by 1,698
Lamas, B., Richard, M. L., Leducq, V., Pham, H.-P., Michel, M.-L., Da Costa, G., Bridonneau, C., Jegou, S., Hoffmann, T. W., Natividad, J. M., et al. (2016) · Nature Medicine · doi:10.1038/nm.4102 · Cited by 1,482
ACE2 links amino acid malnutrition to microbial ecology and intestinal inflammation
Hashimoto, T., Perlot, T., Rehman, A., Trichereau, J., Ishiguro, H., Paolino, M., Sigl, V., Hanada, T., Hanada, R., Lipinski, S., et al. (2012) · Nature · doi:10.1038/nature11228 · Cited by 1,271
Self-citationT cell apoptosis by tryptophan catabolism
Fallarino, F., Grohmann, U., Vacca, C., Bianchi, R., Orabona, C., Spreca, A., Fioretti, M. C., & Puccetti, P. (2002) · Cell Death & Differentiation · doi:10.1038/sj.cdd.4401073 · Cited by 1,022
Coates, M. D., Mahoney, C. R., Linden, D. R., Sampson, J. E., Chen, J., Blaszyk, H., Crowell, M. D., Sharkey, K. A., Gershon, M. D., & Mawe, G. M. (2004) · Gastroenterology · doi:10.1053/j.gastro.2004.03.013 · Cited by 765
THE COLONIC EPITHELIUM IN ULCERATIVE COLITIS: AN ENERGY-DEFICIENCY DISEASE?
Roediger, W. E. W. (1980) · The Lancet · doi:10.1016/s0140-6736(80)91934-0 · Cited by 719
L-Tryptophan: Basic Metabolic Functions, Behavioral Research and Therapeutic Indications
Richard, D. M., Dawes, M. A., Mathias, C. W., Acheson, A., Hill-Kapturczak, N., & Dougherty, D. M. (2009) · International Journal of Tryptophan Research · doi:10.4137/ijtr.s2129 · Cited by 693
Jin, U.-H., Lee, S.-O., Sridharan, G., Lee, K., Davidson, L. A., Jayaraman, A., Chapkin, R. S., Alaniz, R., & Safe, S. (2014) · Molecular Pharmacology · doi:10.1124/mol.113.091165 · Cited by 327
Bohlscheid-Thomas, S. (1997) · International Journal of Epidemiology · doi:10.1093/ije/26.suppl_1.s59 · Cited by 322
Nutritional deficiencies in patients with Crohnʼs disease in remission
Filippi, J., Al-Jaouni, R., Wiroth, J.-B., Hébuterne, X., & Schneider, S. M. (2006) · Inflammatory Bowel Diseases · doi:10.1097/01.mib.0000206541.15963.c3 · Cited by 263
Kim, C. J., Kovacs-Nolan, J. A., Yang, C., Archbold, T., Fan, M. Z., & Mine, Y. (2010) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2009.01.019 · Cited by 218
Hisamatsu, T., Okamoto, S., Hashimoto, M., Muramatsu, T., Andou, A., Uo, M., Kitazume, M. T., Matsuoka, K., Yajima, T., Inoue, N., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0031131 · Cited by 195
Bohlscheid-Thomas, S. (1997) · International Journal of Epidemiology · doi:10.1093/ije/26.suppl_1.s71 · Cited by 195
A functional methylome map of ulcerative colitisPreprint
Häsler, R., Feng, Z., Bäckdahl, L., Spehlmann, M. E., Franke, A., Teschendorff, A. E., Rakyan, V. K., Down, T. A., Wilson, G. A., Feber, A., et al. (2012) · Genome Research · doi:10.1101/gr.138347.112 · Cited by 169
Self-citationSerum Analysis of Tryptophan Catabolism Pathway: Correlation With Crohnʼs Disease Activity
Gupta, N., Thaker, A. I., Kanuri, N. D., Riehl, T. E., Rowley, C. W., Stenson, W. F., & Ciorba, M. A. (2011) · Inflammatory Bowel Diseases · doi:10.1002/ibd.21849 · Cited by 159
Overexpression of indoleamine 2,3-dioxygenase in human inflammatory bowel disease
Wolf, A. M., Wolf, D., Rumpold, H., Moschen, A. R., Kaser, A., Obrist, P., Fuchs, D., Brandacher, G., Winkler, C., Geboes, K., et al. (2004) · Clinical Immunology · doi:10.1016/j.clim.2004.05.004 · Cited by 158
Clarke, G. A., Fitzgerald, P., Cryan, J. F., Cassidy, E., Quigley, E. M. M., & Dinan, T. G. (2009) · BMC Gastroenterology · doi:10.1186/1471-230x-9-6 · Cited by 130
Indoleamine 2,3 dioxygenase in intestinal disease
Ciorba, M. A. (2012) · Current Opinion in Gastroenterology · doi:10.1097/mog.0b013e32835c9cb3 · Cited by 128
Fructose Malabsorption is Associated with Decreased Plasma Tryptophan
Ledochowski, M., Widner, B., Murr, C., Sperner-Unterweger, B., & Fuchs, D. (2001) · Scandinavian Journal of Gastroenterology · doi:10.1080/00365520117856 · Cited by 93
Bokemeyer, B., Hardt, J., Hüppe, D., Prenzler, A., Conrad, S., Düffelmeyer, M., Hartmann, P., Hoffstadt, M., Klugmann, T., Schmidt, C., et al. (2013) · Journal of Crohn s and Colitis · doi:10.1016/j.crohns.2012.02.014 · Cited by 87
Terada, T., Shimada, Y., Pan, X., Kishimoto, K., Sakurai, T., Doi, R., Onodera, H., Katsura, T., Imamura, M., & Inui, K. (2005) · Biochemical Pharmacology · doi:10.1016/j.bcp.2005.09.027 · Cited by 82
Walczak, K., Dąbrowski, W., Langner, E., Zgrajka, W., Piłat, J., Kocki, T., Rzeski, W., & Turski, W. A. (2011) · Scandinavian Journal of Gastroenterology · doi:10.3109/00365521.2011.579159 · Cited by 81
Fructose malabsorption is associated with decreased plasma tryptophan.
Ledochowski, M., Widner, B., Propst-Braunsteiner, T., et al. (1999) · Advances in Experimental Medicine and Biology · doi:10.1080/003655201300051135 · Cited by 76
Control of growth by picolinic acid: Differential response of normal and transformed cells
Fernandez‐Pol, J. A., Bono, V. H., & Johnson, G. S. (1977) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.74.7.2889 · Cited by 69
Forrest, C. M., Gould, S. R., Darlington, L. G., & Stone, T. W. (2003) · Advances in experimental medicine and biology · doi:10.1007/978-1-4615-0135-0_46 · Cited by 69
Gülöksüz, S., Wichers, M., Kenis, G., Rüssel, M. G., Wauters, A., Verkerk, R. M., Arts, B. M. G., & van Os, J. (2013) · PLoS ONE · doi:10.1371/journal.pone.0060435 · Cited by 53
Bettenworth, D., Nowacki, T. M., Ross, M., Kyme, P. A., Schwammbach, D., Kerstiens, L., Thoennissen, G. B., Bokemeyer, C., Hengst, K., Berdel, W. E., et al. (2014) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.201300818 · Cited by 52
Lee, A., Kanuri, N. D., Zhang, Y., Sayuk, G. S., Li, E., & Ciorba, M. A. (2014) · PLoS ONE · doi:10.1371/journal.pone.0115848 · Cited by 39
Pellagra with colitis due to a defect in tryptophan metabolism
Clayton, P. T., Bridges, N., Atherton, D. J., Milla, P. J., Malone, M., & Bender, D. A. (1991) · European Journal of Pediatrics · doi:10.1007/bf01958432 · Cited by 22
Serum Tryptophan in Crohn’s Disease
Beeken, W. L. (1976) · Scandinavian Journal of Gastroenterology · doi:10.1080/00365521.1976.12097180 · Cited by 20
Yau, Y. Y., Leong, R. W. L., Shin, S., Bustamante, S., Pickford, R., Hejazi, L., Campbell, B., & Wasinger, V. C. (2014) · PubMed · Cited by 15
Cited by
Gut Microbiota Regulation of Tryptophan Metabolism in Health and Disease
Agus, A., Planchais, J., & Sokol, H. (2018) · Cell Host & Microbe · doi:10.1016/j.chom.2018.05.003 · Cited by 3,180
Microbial tryptophan catabolites in health and disease
Roager, H. M., & Licht, T. R. (2018) · Nature Communications · doi:10.1038/s41467-018-05470-4 · Cited by 2,236
Gut microbiota-derived metabolites as key actors in inflammatory bowel disease
Lavelle, A., & Sokol, H. (2020) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-019-0258-z · Cited by 2,015
Tryptophan metabolism in health and disease
Xue, C., Li, G., Zheng, Q., Gu, X., Shi, Q., Su, Y., Chu, Q., Yuan, X., Bao, Z., Lu, J., et al. (2023) · Cell Metabolism · doi:10.1016/j.cmet.2023.06.004 · Cited by 961
Intestinal Barrier Dysfunction, LPS Translocation, and Disease Development
Ghosh, S. S., Wang, J., Yannie, P. J., & Ghosh, S. (2020) · Journal of the Endocrine Society · doi:10.1210/jendso/bvz039 · Cited by 759
Metadata
- Authors
- Nikolaus, S., Schulte, B., Al-Massad, N., Thieme, F., Schulte, D. M., Bethge, J., Rehman, A., Tran, F., Aden, K., Häsler, R., Moll, N., Schütze, G., Schwarz, M. J., Waetzig, G. H., Rosenstiel, P., Krawczak, M., Szymczak, S., & Schreiber, S.
- Venue
- Gastroenterology
- Publisher
- Elsevier BV
- Published
- 2017-12
- Volume
- 153
- Issue
- 6
- Pages
- 1504-1516.e2
- ISSN
- 0016-5085 (ISSN-L)
- OpenAlex
- W2745643218
- Cited by
- 602
- References
- 35
- FWCI
- 16.86
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.